Farnesylation of Ras is important for the interaction with phosphoinositide 3-kinase gamma
about
Activated Ras as a Therapeutic Target: Constraints on Directly Targeting Ras Isoforms and Wild-Type versus Mutated ProteinsRas-induced cellular events (review)H-Ras and phosphoinositide 3-kinase cooperate to induce alpha(1,3)-fucosyltransferase VII expression in Jurkat T cellsA specific role of phosphatidylinositol 3-kinase gamma. A regulation of autonomic Ca(2)+ oscillations in cardiac cellsA novel role of farnesylation in targeting a mitotic checkpoint protein, human Spindly, to kinetochoresRig is a novel Ras-related protein and potential neural tumor suppressorRas Dimer Formation as a New Signaling Mechanism and Potential Cancer Therapeutic Target.Human RAS superfamily proteins and related GTPases.Different inhibition of Gβγ-stimulated class IB phosphoinositide 3-kinase (PI3K) variants by a monoclonal antibody. Specific function of p101 as a Gβγ-dependent regulator of PI3Kγ enzymatic activity.Ras activation in Jurkat T cells following low-grade stimulation of the T-cell receptor is specific to N-Ras and occurs only on the Golgi apparatus.Malignant peripheral nerve sheath tumour (MPNST): the clinical implications of cellular signalling pathways.Apoptosis signaling by the novel compound 3-Cl-AHPC involves increased EGFR proteolysis and accompanying decreased phosphatidylinositol 3-kinase and AKT kinase activities.Carboxyl methylation of Ras regulates membrane targeting and effector engagement.High affinity for farnesyltransferase and alternative prenylation contribute individually to K-Ras4B resistance to farnesyltransferase inhibitors.Distinct rates of palmitate turnover on membrane-bound cellular and oncogenic H-ras.Inhibition of RAS activation due to a homozygous ezrin variant in patients with profound intellectual disability.Regulation of Raf by Akt controls growth and differentiation in vascular smooth muscle cells.Secondary structure of lipidated Ras bound to a lipid bilayer.Mutation of Ha-Ras C Terminus Changes Effector Pathway Utilization
P2860
Q27027458-5757B049-B144-4F5F-922C-9B89AC8A6B56Q28138814-2AFA4639-EC08-438E-9A2D-736B939EF087Q28272904-9BB66A7D-F856-47AB-BAC6-10ED1ED9446EQ28573309-C5801C8D-37F7-44B0-B2B1-5A07D6455A4EQ30635394-3265C5D3-24AD-4DEE-BF3D-107D37CD7B15Q31095737-39C29027-3291-4EC4-989A-9272523EB7EDQ33646519-037FB56F-4A72-4DC3-A2AD-EA9D454E5C25Q33689727-329A92AC-5A51-4FEA-B6F2-B6D9216FF830Q36306280-F752A979-0616-4E4E-A604-431AAC424E71Q37274925-C42DF202-07E7-4E6C-9268-78E79826F3A5Q37616238-3EE54406-3B7F-43F5-97EA-79658F0EC639Q40586198-8148055B-3F56-4B16-BC54-9089386641A9Q40609836-9BE2F361-BB5D-4727-988E-B4BF40F16D2CQ42798921-7D452B07-41C3-4F95-932B-5818E3619F7AQ42804098-ECC61FB7-DB9B-4764-96C2-782FB4F5515BQ42832214-A156FB1C-F33F-4F50-8FD2-76C8714F9A70Q43666441-8515A845-9C33-42E7-88C5-9EDABF80C551Q46236291-407A0DF4-9F53-44E6-B7D1-419EF4B7889AQ57371882-1C53F393-244D-46F1-A499-17E13247C708
P2860
Farnesylation of Ras is important for the interaction with phosphoinositide 3-kinase gamma
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Farnesylation of Ras is import ...... hosphoinositide 3-kinase gamma
@ast
Farnesylation of Ras is import ...... hosphoinositide 3-kinase gamma
@en
Farnesylation of Ras is import ...... hosphoinositide 3-kinase gamma
@nl
type
label
Farnesylation of Ras is import ...... hosphoinositide 3-kinase gamma
@ast
Farnesylation of Ras is import ...... hosphoinositide 3-kinase gamma
@en
Farnesylation of Ras is import ...... hosphoinositide 3-kinase gamma
@nl
prefLabel
Farnesylation of Ras is import ...... hosphoinositide 3-kinase gamma
@ast
Farnesylation of Ras is import ...... hosphoinositide 3-kinase gamma
@en
Farnesylation of Ras is import ...... hosphoinositide 3-kinase gamma
@nl
P2093
P2860
P1433
P1476
Farnesylation of Ras is import ...... hosphoinositide 3-kinase gamma
@en
P2093
P2860
P356
10.1046/J.1432-1327.1999.00815.X
P407
P577
1999-11-01T00:00:00Z